Literature DB >> 12759339

Hoxb13 knockout adult skin exhibits high levels of hyaluronan and enhanced wound healing.

Judith A Mack1, Susan R Abramson, Yixen Ben, Jerusha C Coffin, James K Rothrock, Edward V Maytin, Vincent C Hascall, Corey Largman, Eric J Stelnicki.   

Abstract

In contrast to adult cutaneous wound repair, early gestational fetal cutaneous wounds heal by a process of regeneration, resulting in little or no scarring. Previous studies indicate that down-regulation of HoxB13, a member of the highly conserved family of Hox transcription factors, occurs during fetal scarless wound healing. No down-regulation was noted in adult wounds. Here, we evaluate healing of adult cutaneous wounds in Hoxb13 knockout (KO) mice, hypothesizing that loss of Hoxb13 in adult skin should result in enhanced wound healing. Tensiometry was used to measure the tensile strength of incisional wounds over a 60-day time course; overall, Hoxb13 KO wounds are significantly stronger than wild-type (WT). Histological evaluation of incisional wounds shows that 7-day-old Hoxb13 KO wounds are significantly smaller and that 60-day-old Hoxb13 KO wounds exhibit a more normal collagen architecture compared with WT wounds. We also find that excisional wounds close at a faster rate in Hoxb13 KO mice. Biochemical and histochemical analyses show that Hoxb13 KO skin contains significantly elevated levels of hyaluronan. Because higher levels of hyaluronan and enhanced wound healing are characteristics of fetal skin, we conclude that loss of Hoxb13 produces a more "fetal-like" state in adult skin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759339     DOI: 10.1096/fj.02-0959fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  27 in total

1.  Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre.

Authors:  Victoria K Shanmugam; Amber Schilling; Anthony Germinario; Mihriye Mete; Paul Kim; John Steinberg; Christopher E Attinger
Journal:  Int Wound J       Date:  2011-12-14       Impact factor: 3.315

Review 2.  Similarities and differences between induced organ regeneration in adults and early foetal regeneration.

Authors:  Ioannis V Yannas
Journal:  J R Soc Interface       Date:  2005-12-22       Impact factor: 4.118

Review 3.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.

Authors:  Anthony D Metcalfe; Mark W J Ferguson
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

4.  Tensile properties of the murine ventral vertical midline incision.

Authors:  Mark A Carlson; Dennis Chakkalakal
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

Review 5.  Hyaluronan: More than just a wrinkle filler.

Authors:  Edward V Maytin
Journal:  Glycobiology       Date:  2016-03-09       Impact factor: 4.313

6.  Homeostasis of hyaluronic acid in normal and scarred vocal folds.

Authors:  Ichiro Tateya; Tomoko Tateya; Makoto Watanuki; Diane M Bless
Journal:  J Voice       Date:  2014-12-09       Impact factor: 2.009

Review 7.  Wound-healing studies in transgenic and knockout mice.

Authors:  Richard Grose; Sabine Werner
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

8.  Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice.

Authors:  Judith A Mack; Edward V Maytin
Journal:  J Invest Dermatol       Date:  2009-09-17       Impact factor: 8.551

9.  Hyaluronan participates in the epidermal response to disruption of the permeability barrier in vivo.

Authors:  Edward V Maytin; Helen H Chung; V Mani Seetharaman
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

10.  Wounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding egf and activation of the EGFR.

Authors:  James Monslow; Nobuyuki Sato; Judith A Mack; Edward V Maytin
Journal:  J Invest Dermatol       Date:  2009-02-19       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.